Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia

Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) are associated with systemic inflammatory or autoimmune diseases in 10-20% of cases. Immune thrombocytopenia (ITP) is among the reportedly associated diseases, but large studies assessing the association are lacking. It is un...

Descripción completa

Detalles Bibliográficos
Autores principales: Jachiet, Vincent, Moulis, Guillaume, Hadjadj, Jérome, Seguier, Julie, Laribi, Kamel, Schleinitz, Nicolas, Vey, Norbert, Sacre, Karim, Godeau, Bertrand, Beyne-Rauzy, Odile, Bouvet, Romain, Broner, Jonathan, Brun, Natacha, Comont, Thibault, Gaudin, Clément, Lambotte, Olivier, Le Clech, Lenaïg, Peterlin, Pierre, Roy-Peaud, Frédérique, Salvado, Clémentine, Versini, Mathilde, Isnard, Françoise, Kahn, Jean Emmanuel, Gobert, Delphine, Adès, Lionel, Fenaux, Pierre, Fain, Olivier, Mekinian, Arsène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094121/
https://www.ncbi.nlm.nih.gov/pubmed/33626866
http://dx.doi.org/10.3324/haematol.2020.272559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094121/
https://www.ncbi.nlm.nih.gov/pubmed/33626866
http://dx.doi.org/10.3324/haematol.2020.272559

Ejemplares similares